Welcome, Guest
Username: Password: Remember me
Adult Stem Cell News and Developments other than Cytori
  • Page:
  • 1

TOPIC: Cellular Biomedicine: Real Company or Scam

Cellular Biomedicine: Real Company or Scam 05 Jun 2015 12:59 #4622

  • Wall Street Titan
  • Wall Street Titan's Avatar Topic Author
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 901
  • Thank you received: 148
CBMG has $465,000,000 market cap and describes itslf as follows:

Cellular Biomedicine Group, Inc. develops proprietary cell therapies for the treatment of certain degenerative diseases and cancers. Our developmental stem cell, progenitor cell, and immune cell projects are the result of research and development by scientists and doctors from China and the United States. Our flagship GMP facility, consisting of eight independent cell production lines, is designed, certified and managed according to U.S. standards. To learn more about CBMG, please visit: www.cellbiomedgroup.com


Press release this morning:

10:00 AM EDT, 06/05/2015 (MT Newswires) -- Cellular Biomedicine Group(CBMG) shares are higher on Friday after research was published on the use of human adipose-derived progenitor cells (haMPCs) to treat knee osteoarthritis (KOA) in a peer-reviewed scientific journal.

The publication, titled "Human Adipose-Derived Mesenchymal Progenitor Cells Engraft into Rabbit Articular Cartilage," appears online in the May edition of the International Journal of Molecular Sciences.

"We are very pleased to see this important pre-clinical data published on one of the applications of our regenerative medicine stem cell platform," said company CEO Dr. William (Wei) Cao. "The data bolsters our belief in the effectiveness of our lead product candidate, ReJoin, an haMPC therapy in treating KOA and promoting the regeneration of cartilage."

The cell therapy company is currently running a Phase IIb clinical trial of its ReJoin therapy for knee osteoarthritis and previously released positive 24-week interim data. It expects to complete Phase IIb 12-month patient follow-up by the fourth quarter of 2015.


However, this article on SA makes a compelling case that it is a scam.

I haven't done to much DD on it but thought it was an interesting story to share.

Please Log in or Create an account to join the conversation.

  • Page:
  • 1
Time to create page: 0.067 seconds

Copyright Information

Copyright Fas Kuiters © 2016 young-foxes.com. All Rights Reserved.
This page is made with Joomla CMS and its various templates designed by Fas Kuiters with the excellent Themler tool.

 

 

Shared Spreadsheet Links

DOV´s Revised Projections for the Periods 2017 until 2020

Shareble link : HERE

Fas Kuiters Websites